F3B6
F3B6
规格:
货期:
编号:TS212195
品牌:Testobio
| 产品名称： | F3B6 |
|---|---|
| 商品货号： | TS212195 |
| Organism： | human (B cell); mouse (myeloma) |
| Cell Type： | hybridoma: B lymphocyte |
| Product Format： | frozen |
| Morphology： | lymphoblast |
| Culture Properties： | suspension |
| Biosafety Level： | 1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Applications： | The cells are resistant to 6-thioguanine. This line is suitable for fusing to human B cells for the production of human monoclonal antibodies. |
| Disclosure： | This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC. |
| Derivation： | This line is suitable for fusing to human B cells for the production of human monoclonal antibodies. |
| Comments： | Fusion of human peripheral blood B cell with NS-1 myeloma cells. The cells are resistant to 6-thioguanine. This line is suitable for fusing to human B cells for the production of human monoclonal antibodies. |
| Complete Growth Medium： | Culture Medium: HL-1 medium, 99%; fetal bovine serum, 1%. Iscoves modified Dulbeccos medium with 10% fetal bovine serum has been used as an alternative to HL-1. |
| Subculturing： | Medium Renewal: Every 2 to 3 days Cultures can be maintained by addition or replacement of fresh medium. Start cultures at 5 X 10 exp4 cells/ml and maintain between 5 X 10 exp4 and 1 X 10 exp6 cells/ml. |
| Cryopreservation： | HL-1 medium, 82.5%, human serum albumin, 10%; DMSO, 7.5% |
| Name of Depositor： | Cetus Corp. |
| Deposited As： | human (B cell); mouse (myeloma) |
| U.S. Patent Number： | |
| References： | Larrick JW, Raubitschek AA. Pseudomonas aeruginosa exotoxin A antibodies, their preparation and use. US Patent 4,677,070 dated Jun 30 1987 |
首页 >
产品中心
>
微生物培养
>
菌株
>
null
>
F3B6
产品中心 Product Center
联系我们CONTACT US
-
0574-87917803
24小时服务热线 -
testobio@163.com
销售邮箱 -
浙江省宁波市高新区晶辉路866弄33号智造港E4幢3楼
地址
联系方式
-
章丽敏
17757489010 -
朱静
18067106081 -
李晴
18067408036 -
李晶晶
13375187189 -
周雪
13372109301
| 产品名称： | F3B6 |
|---|---|
| 商品货号： | TS212195 |
| Organism： | human (B cell); mouse (myeloma) |
| Cell Type： | hybridoma: B lymphocyte |
| Product Format： | frozen |
| Morphology： | lymphoblast |
| Culture Properties： | suspension |
| Biosafety Level： | 1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Applications： | The cells are resistant to 6-thioguanine. This line is suitable for fusing to human B cells for the production of human monoclonal antibodies. |
| Disclosure： | This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC. |
| Derivation： | This line is suitable for fusing to human B cells for the production of human monoclonal antibodies. |
| Comments： | Fusion of human peripheral blood B cell with NS-1 myeloma cells. The cells are resistant to 6-thioguanine. This line is suitable for fusing to human B cells for the production of human monoclonal antibodies. |
| Complete Growth Medium： | Culture Medium: HL-1 medium, 99%; fetal bovine serum, 1%. Iscoves modified Dulbeccos medium with 10% fetal bovine serum has been used as an alternative to HL-1. |
| Subculturing： | Medium Renewal: Every 2 to 3 days Cultures can be maintained by addition or replacement of fresh medium. Start cultures at 5 X 10 exp4 cells/ml and maintain between 5 X 10 exp4 and 1 X 10 exp6 cells/ml. |
| Cryopreservation： | HL-1 medium, 82.5%, human serum albumin, 10%; DMSO, 7.5% |
| Name of Depositor： | Cetus Corp. |
| Deposited As： | human (B cell); mouse (myeloma) |
| U.S. Patent Number： | |
| References： | Larrick JW, Raubitschek AA. Pseudomonas aeruginosa exotoxin A antibodies, their preparation and use. US Patent 4,677,070 dated Jun 30 1987 |
